Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin II Receptor Balance in Post-Preeclampsia Vessel Function
NCT06157580Phase 1Completed
- Start
- Dec 2023
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms). Primary endpoints: Change in microvascular angiotensin II type 2 receptor-mediated dilation response at 4 hours and Change in microvascular angiotensin II-mediated constriction response at 4 hours. Started Dec 2023; status: completed.
Beyond the preview
Go deeper on NCT06157580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06157580.